UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016921
Receipt number R000019640
Scientific Title Efficacy of SGLT2 inhibitors on bone mineral density in patients with type 2 diabetes
Date of disclosure of the study information 2015/03/26
Last modified on 2015/03/26 12:34:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of SGLT2 inhibitors on bone mineral density in patients with type 2 diabetes

Acronym

Efficacy of SGLT2 inhibitors on bone mineral density in patients with type 2 diabetes

Scientific Title

Efficacy of SGLT2 inhibitors on bone mineral density in patients with type 2 diabetes

Scientific Title:Acronym

Efficacy of SGLT2 inhibitors on bone mineral density in patients with type 2 diabetes

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate effects of SGLT2 inhibitors on bone mineral density in patients with type 2 diabetes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Bone mineral density compared to that of a young adult mean

Key secondary outcomes

Hemoglobin A1c level, body mass index, renal function parameters in blood and urine and serum lipid profiles


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Luseogliflozin

Interventions/Control_2

Dapagliflozin

Interventions/Control_3

Tofogliflozin

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Type 2 diabetes patients.
Obtained written informed consent from the patients before participation.

Key exclusion criteria

Complicated severe nephropathy.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masataka Kusunoki

Organization

Aichi Medical University

Division name

Medical Clinic

Zip code


Address

2-12-1, Higashisakura, Higashi-ku, Nagoya

TEL

052-931-2261

Email

info@tonyo.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masataka Kusunoki

Organization

Aichi Medical University

Division name

Medical Clinic

Zip code


Address

2-12-1, Higashisakura, Higashi-ku, Nagoya

TEL

052-931-2261

Homepage URL


Email

info@tonyo.jp


Sponsor or person

Institute

Akishima Clinic

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団あきしまクリニック(愛知県)


Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 05 Month 31 Day

Last follow-up date

2015 Year 03 Month 11 Day

Date of closure to data entry

2015 Year 03 Month 17 Day

Date trial data considered complete

2015 Year 03 Month 24 Day

Date analysis concluded

2015 Year 03 Month 25 Day


Other

Other related information



Management information

Registered date

2015 Year 03 Month 26 Day

Last modified on

2015 Year 03 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019640


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name